Cargando…
One-step artificial antigen presenting cell-based vaccines induce potent effector CD8 T cell responses
The production and wide use of artificial antigen presenting cells (aAPCs) in the clinic as cancer immunotherapeutics are hindered by the need of identifying immunogenic cancer antigens and production of recombinant patient-specific major histocompatibility complexes (MHC) loaded with these peptides...
Autores principales: | Su, Qingtai, Igyártó, Botond Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908577/ https://www.ncbi.nlm.nih.gov/pubmed/31831802 http://dx.doi.org/10.1038/s41598-019-55286-5 |
Ejemplares similares
-
Cognate Antigen Stimulation Generates Potent CD8(+) Inflammatory Effector T Cells
por: Sung, Hsueh-Cheng, et al.
Publicado: (2013) -
Brief communication: Long-term absence of Langerhans cells alters the gene expression profile of keratinocytes and dendritic epidermal T cells
por: Su, Qingtai, et al.
Publicado: (2020) -
Dendritic Cells Overcome Cre/Lox Induced Gene Deficiency by Siphoning Material From Neighboring Cells Using Intracellular Monitoring—a Novel Mechanism of Antigen Acquisition
por: Herbst, Christopher H., et al.
Publicado: (2023) -
Multimodal identification of rare potent effector CD8 T cells in solid tumors
por: Ray, Arja, et al.
Publicado: (2023) -
“Don’t Look Up” Your Science—Herd Immunity or Herd Mentality?
por: Igyártó, Botond Z.
Publicado: (2022)